{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:48:55Z","timestamp":1778557735328,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Program of Postgraduate Research Innovation of Tianjin","award":["2019YJSS093"],"award-info":[{"award-number":["2019YJSS093"]}]},{"name":"the Youth Program of the National Natural Science Foundation of China","award":["32202760"],"award-info":[{"award-number":["32202760"]}]},{"name":"the Open Fund of Key Laboratory of Smart Breeding (Co-construction by Ministry and Province), Ministry of Agriculture and Rural Affairs","award":["2023-TJAUKLSBF-2103"],"award-info":[{"award-number":["2023-TJAUKLSBF-2103"]}]},{"name":"the Research Project of Tianjin Education Commission","award":["2019KJ032"],"award-info":[{"award-number":["2019KJ032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10637-024-01453-z","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T14:14:08Z","timestamp":1719497648000},"page":"428-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel recombinant adenovirus expressing apoptin and melittin genes kills hepatocellular carcinoma cells and inhibits the growth of ectopic tumor"],"prefix":"10.1007","volume":"42","author":[{"given":"Jingqiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinling","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"3","key":"1453_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"1453_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551","DOI":"10.3322\/caac.21551"},{"issue":"3","key":"1453_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10439-018-02177-x","volume":"47","author":"A Andreozzi","year":"2019","unstructured":"Andreozzi A, Brunese L, Iasiello M, Tucci C, Vanoli GP (2019) Modeling heat transfer in tumors: a review of Thermal therapies. Ann Biomed Eng 47(3):676\u2013693. https:\/\/doi.org\/10.1007\/s10439-018-02177-x","journal-title":"Ann Biomed Eng"},{"issue":"1","key":"1453_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12010-015-1567-5","volume":"176","author":"PK Singh","year":"2015","unstructured":"Singh PK, Tiwari AK, Rajmani RS et al (2015) Apoptin as a potential viral gene Oncotherapeutic Agent. Appl Biochem Biotechnol 176(1):196\u2013212. https:\/\/doi.org\/10.1007\/s12010-015-1567-5","journal-title":"Appl Biochem Biotechnol"},{"issue":"1","key":"1453_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12985-017-0713-9","volume":"14","author":"Y Wang","year":"2017","unstructured":"Wang Y, Song X, Gao H et al (2017) C-terminal region of apoptin affects chicken anemia virus replication and virulence. Virol J 14(1):38. https:\/\/doi.org\/10.1186\/s12985-017-0713-9","journal-title":"Virol J"},{"issue":"19","key":"1453_CR6","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1242\/jcs.02580","volume":"118","author":"S Maddika","year":"2005","unstructured":"Maddika S (2005) Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci 118(19):4485\u20134493. https:\/\/doi.org\/10.1242\/jcs.02580","journal-title":"J Cell Sci"},{"issue":"5","key":"1453_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ymthe.2006.06.005","volume":"14","author":"X Liu","year":"2006","unstructured":"Liu X, Elojeimy S, El-Zawahry AM et al (2006) Modulation of Ceramide Metabolism enhances viral protein apoptin\u2019s cytotoxicity in prostate Cancer. Mol Ther 14(5):637\u2013646. https:\/\/doi.org\/10.1016\/j.ymthe.2006.06.005","journal-title":"Mol Ther"},{"issue":"June","key":"1453_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2020.00524","volume":"8","author":"WA Malla","year":"2020","unstructured":"Malla WA, Arora R, Khan RIN, Mahajan S, Tiwari AK (2020) Apoptin as a Tumor-Specific Therapeutic Agent: current perspective on mechanism of Action and Delivery systems. Front Cell Dev Biol 8(June):1\u201315. https:\/\/doi.org\/10.3389\/fcell.2020.00524","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"1453_CR9","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1039\/d2sc04481a","volume":"14","author":"J Wyatt","year":"2023","unstructured":"Wyatt J, Chan YK, Hess M, Tavassoli M, M\u00fcller MM (2023) Semisynthesis reveals apoptin as a tumour-selective protein prodrug that causes cytoskeletal collapse. Chem Sci 14(14):3881\u20133892. https:\/\/doi.org\/10.1039\/d2sc04481a","journal-title":"Chem Sci"},{"issue":"7","key":"1453_CR10","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1002\/cam4.5528","volume":"12","author":"X Yu","year":"2023","unstructured":"Yu X, Wang T, Li Y et al (2023) Apoptin causes apoptosis in HepG-2 cells via Ca2\u2009+\u2009imbalance and activation of the mitochondrial apoptotic pathway. Cancer Med 12(7):8306\u20138318. https:\/\/doi.org\/10.1002\/cam4.5528","journal-title":"Cancer Med"},{"issue":"12","key":"1453_CR11","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2174\/092986706776872871","volume":"13","author":"K Wagstaff","year":"2006","unstructured":"Wagstaff K, Jans D (2006) Protein transduction: cell penetrating peptides and their therapeutic applications. Curr Med Chem 13(12):1371\u20131387. https:\/\/doi.org\/10.2174\/092986706776872871","journal-title":"Curr Med Chem"},{"issue":"1","key":"1453_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.63.1.1-8.1989","volume":"63","author":"S Ruben","year":"1989","unstructured":"Ruben S, Perkins A, Purcell R et al (1989) Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 63(1):1\u20138. https:\/\/doi.org\/10.1128\/JVI.63.1.1-8.1989","journal-title":"J Virol"},{"issue":"3","key":"1453_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1389203719666180612084615","volume":"20","author":"C Lyu","year":"2019","unstructured":"Lyu C, Fang F, Li B (2019) Anti-tumor effects of Melittin and its potential applications in clinic. Curr Protein Pept Sci 20(3):240\u2013250. https:\/\/doi.org\/10.2174\/1389203719666180612084615","journal-title":"Curr Protein Pept Sci"},{"key":"1453_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","volume":"402","author":"I Rady","year":"2017","unstructured":"Rady I, Siddiqui IA, Rady M, Mukhtar H (2017) Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett 402:16\u201331. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.010","journal-title":"Cancer Lett"},{"issue":"1","key":"1453_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1568026615666150703115919","volume":"16","author":"E Jamasbi","year":"2015","unstructured":"Jamasbi E, Mularski A, Separovic F (2015) Model membrane and cell studies of antimicrobial activity of Melittin Analogues. Curr Top Med Chem 16(1):40\u201345. https:\/\/doi.org\/10.2174\/1568026615666150703115919","journal-title":"Curr Top Med Chem"},{"issue":"February","key":"1453_CR16","doi-asserted-by":"publisher","first-page":"110236","DOI":"10.1016\/j.biopha.2020.110236","volume":"128","author":"X Lv","year":"2020","unstructured":"Lv X, Zhang C, Shuaizhen Q, Yu R, Zheng Y (2020) Design of integrin \u03b1v\u03b23 targeting self-assembled protein nanoparticles with RGD peptide. Biomed Pharmacother 128(February):110236. https:\/\/doi.org\/10.1016\/j.biopha.2020.110236","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1453_CR17","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1080\/21645515.2016.1165908","volume":"12","author":"C Zhang","year":"2016","unstructured":"Zhang C, Zhou D (2016) Adenoviral vector-based strategies against infectious disease and cancer. Hum Vaccin Immunother 12(8):2064\u20132074. https:\/\/doi.org\/10.1080\/21645515.2016.1165908","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1453_CR18","doi-asserted-by":"publisher","first-page":"100639","DOI":"10.1016\/j.currproblcancer.2020.100639","volume":"45","author":"NH Goradel","year":"2021","unstructured":"Goradel NH, Baker AT, Arashkia A, Ebrahimi N, Ghorghanlu S, Negahdari B (2021) Oncolytic virotherapy: challenges and solutions. Curr Probl Cancer 45(1):100639. https:\/\/doi.org\/10.1016\/j.currproblcancer.2020.100639","journal-title":"Curr Probl Cancer"},{"issue":"3","key":"1453_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout SZ, Miller DM, Emerick KS, Kaufman HL (2023) Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol 20(3):160\u2013177. https:\/\/doi.org\/10.1038\/s41571-022-00719-w","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1453_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G (2021) Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther 6(1):53. https:\/\/doi.org\/10.1038\/s41392-021-00487-6","journal-title":"Signal Transduct Target Ther"},{"issue":"10240","key":"1453_CR21","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"395","author":"F-C Zhu","year":"2020","unstructured":"Zhu F-C, Li Y-H, Guan X-H et al (2020) Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 395(10240):1845\u20131854. https:\/\/doi.org\/10.1016\/S0140-6736(20)31208-3","journal-title":"Lancet"},{"issue":"10069","key":"1453_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","volume":"389","author":"F-C Zhu","year":"2017","unstructured":"Zhu F-C, Wurie AH, Hou L-H et al (2017) Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 389(10069):621\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(16)32617-4","journal-title":"Lancet"},{"key":"1453_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9832467","volume":"2018","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Liu F, Li C et al (2018) Construction and characterization of Adenovirus vectors encoding Aspartate- \u03b2 -Hydroxylase to preliminary application in Immunotherapy of Hepatocellular Carcinoma. J Immunol Res 2018:1\u201310. https:\/\/doi.org\/10.1155\/2018\/9832467","journal-title":"J Immunol Res"},{"issue":"18","key":"1453_CR24","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.3390\/cancers14184512","volume":"14","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Lu Z, Ding J et al (2022) Therapeutic Adenovirus Vaccine Combined immunization with IL-12 induces potent CD8\u2009+\u2009T cell Anti-tumor Immunity in Hepatocellular Carcinoma. Cancers (Basel) 14(18):4512. https:\/\/doi.org\/10.3390\/cancers14184512","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1453_CR25","doi-asserted-by":"publisher","first-page":"102442","DOI":"10.1016\/j.jbc.2022.102442","volume":"298","author":"T-H Chu","year":"2022","unstructured":"Chu T-H, Ko C-Y, Tai P-H et al (2022) Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma. J Biol Chem 298(10):102442. https:\/\/doi.org\/10.1016\/j.jbc.2022.102442","journal-title":"J Biol Chem"},{"issue":"2","key":"1453_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.7150\/ijbs.64350","volume":"18","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li Y, Zhu Y et al (2022) Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. Int J Biol Sci 18(2):717\u2013730. https:\/\/doi.org\/10.7150\/ijbs.64350","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1453_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-022-00940-1","volume":"20","author":"Y Li","year":"2022","unstructured":"Li Y, Shang C, Liu Z et al (2022) Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma. Cell Commun Signal 20(1):1\u201315. https:\/\/doi.org\/10.1186\/s12964-022-00940-1","journal-title":"Cell Commun Signal"},{"key":"1453_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1568009623666221025150239","volume":"23","author":"G Song","year":"2022","unstructured":"Song G, Shang C, Zhu Y et al (2022) Apoptin inhibits glycolysis and regulates autophagy by targeting pyruvate kinase M2 (PKM2) in lung cancer A549 cells. Curr Cancer Drug Targets 23:1\u201314. https:\/\/doi.org\/10.2174\/1568009623666221025150239","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"1453_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12964-022-00940-1","volume":"20","author":"Y Li","year":"2022","unstructured":"Li Y, Shang C, Liu Z et al (2022) Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma. Cell Commun Signal 20(1):134. https:\/\/doi.org\/10.1186\/s12964-022-00940-1","journal-title":"Cell Commun Signal"},{"issue":"7","key":"1453_CR30","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1002\/cam4.5528","volume":"12","author":"X Yu","year":"2023","unstructured":"Yu X, Wang T, Li Y et al (2023) Apoptin causes apoptosis in <\u2009scp\u2009>\u2009HepG -2 cells via ca 2+ imbalance and activation of the mitochondrial apoptotic pathway. Cancer Med 12(7):8306\u20138318. https:\/\/doi.org\/10.1002\/cam4.5528","journal-title":"Cancer Med"},{"key":"1453_CR31","doi-asserted-by":"publisher","unstructured":"Lv Y, Chen X, Chen Z et al (2022) Melittin Tryptophan Substitution with a fluorescent amino acid reveals the structural basis of selective antitumor effect and subcellular localization in Tumor cells. Toxins (Basel) 14(7). https:\/\/doi.org\/10.3390\/toxins14070428","DOI":"10.3390\/toxins14070428"},{"issue":"1","key":"1453_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-023-02223-4","volume":"21","author":"X Yu","year":"2023","unstructured":"Yu X, Jia S, Yu S et al (2023) Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies. J Nanobiotechnol 21(1):1\u201322. https:\/\/doi.org\/10.1186\/s12951-023-02223-4","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1453_CR33","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41467-019-08538-x","volume":"10","author":"X Yu","year":"2019","unstructured":"Yu X, Chen L, Liu J et al (2019) Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis. Nat Commun 10(1):574. https:\/\/doi.org\/10.1038\/s41467-019-08538-x","journal-title":"Nat Commun"},{"issue":"1","key":"1453_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-017-0442-y","volume":"10","author":"J Mao","year":"2017","unstructured":"Mao J, Liu S, Ai M et al (2017) A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety. J Hematol Oncol 10(1):71. https:\/\/doi.org\/10.1186\/s13045-017-0442-y","journal-title":"J Hematol Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-024-01453-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:06:17Z","timestamp":1723716377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-024-01453-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1007\/s10637-024-01453-z","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was reviewed and approved by the Animal Ethical and Welfare Committee of Tianjin Agricultural University (Approval number 2022LLSC25) on 16 March 2022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}